Expert Insights | De Novo

Explore practical guidance to help medical technology teams reduce risk, make informed decisions, and bring life-changing products to patients faster.
All TopicsNewsMedical DevicesRegulationsSoftwareDocumentsQualityEUEngineeringPost-MarketRisk ManagementDe NovoEuropean UnionGlobalHuman FactorsQuality SystemsRisk AnalysisSterilizationUK
Understanding FDA’s NEW Draft Guidance on the De Novo eSTAR Program
purple star
News

Understanding FDA’s NEW Draft Guidance on the De Novo eSTAR Program

October 11, 2023 4 min read

Patients Are Waiting.

Every submission, study, inspection, and commercialization decision moves a patient closer to the technology they're waiting for. Partner with Medicept to navigate every milestone with clarity, continuity, and confidence.